THE EFFECT OF IL28B POLYMORPHISMS ON VIROLOGIC RESPONSE TO TREATMENT WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN (SOC) ADDED TO ABT-450/RITONAVIR (ABT-450/R), ABT-333, OR ABT-072

被引：5
|
作者：
Gaultier, I. [1 ]
Cohen, D. E. [1 ]
Bhathena, A. [1 ]
Idler, K. [1 ]
Larsen, L. M. [1 ]
Podsadecki, T. [1 ]
Bernstein, B. [1 ]
机构：
[1] Abbott, Abbott Pk, IL USA
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)61329-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1327
引用
收藏
页码：S523 / S523
页数：1
相关论文
共 38 条
  • [31] TURQUOISE-II: SVR12 RATES OF 92-96% IN 380 HEPATITIS C VIRUS GENOTYPE 1-INFECTED ADULTS WITH COMPENSATED CIRRHOSIS TREATED WITH ABT-450/R/ABT-267 AND ABT-333 PLUS RIBAVIRIN (3D+RBV)
    Poordad, F.
    Hezode, C.
    Trinh, R.
    Kowdley, K. V.
    Zeuzem, S.
    Agarwal, K.
    Shiffman, M. L.
    Wedemeyer, H.
    Berg, T.
    Yoshida, E. M.
    Forns, X.
    Lovell, S. S.
    Da Silva-Tillmann, B.
    Campbell, A. L.
    Podsadecki, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S523 - S523
  • [32] ABT-072 OR ABT-333 COMBINED WITH PEGYLATED INTERFERON/RIBAVIRIN AFTER 3-DAY MONOTHERAPY IN HCV GENOTYPE 1 (GT1)-INFECTED TREATMENT-NAIVE SUBJECTS: 12-WEEK SUSTAINED VIROLOGIC RESPONSE (SVR12) AND SAFETY RESULTS
    Poordad, F.
    Lawitz, E.
    DeJesus, E.
    Kowdley, K. V.
    Gaultier, I.
    Cohen, D. E.
    Xie, W.
    Larsen, L.
    Pilot-Matias, T.
    Koev, G.
    Dumas, E.
    Podsadecki, T.
    Bernstein, B.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S478 - S478
  • [33] PEARL-III: 12 WEEKS OF ABT-450/R/267+ABT-333 ACHIEVED SVR IN >99% OF 419 TREATMENT-NAIVE HCV GENOTYPE 1B-INFECTED ADULTS WITH OR WITHOUT RIBAVIRIN
    Ferenci, P.
    Nyberg, A.
    Enayati, P.
    Bernstein, D.
    Baruch, Y.
    Caruntu, F. A.
    Chulanov, V.
    Janczewska, E.
    Younes, Z.
    Marinho, R. T.
    Rizzardini, G.
    Gervain, J.
    Planas, R.
    Moreno, C.
    Xie, W.
    Cohen, D.
    King, M.
    Podsadecki, T.
    Reddy, K. R.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S527 - S527
  • [34] Low Relapse Rate Leads to High Concordance of SVR4 and SVR12 with SVR24 After Treatment with ABT-450/r, ABT-267, ABT-333+Ribavirin in Patients with Chronic HCV Genotype 1 Infection in the AVIATOR Study
    Poordad, Fred
    Agarwal, Kosh
    Younes, Ziad
    Cohen, Daniel E.
    Xie, Wangang
    Podsadecki, Thomas
    HEPATOLOGY, 2013, 58 : 735A - 736A
  • [35] High Sustained Virologic Response Rates in Liver Transplant Recipients With Recurrent HCV Genotype 1 Infection Receiving ABT-450/r/Ombitasvir plus Dasabuvir Plus Ribavirin
    Mantry, Parvez S.
    Kwo, Paul Y.
    Coakley, Eoin
    Te, Helen S.
    Vargas, Hugo E.
    Brown, Robert S.
    Gordon, Fredric D.
    Levitsky, Josh
    Terrault, Norah
    Burton, James R.
    Xie, Wangang
    Setze, Carolyn
    Badri, Prajakta
    Vilchez, Regis A.
    Forns, Xavier
    HEPATOLOGY, 2014, 60 : 298A - 299A
  • [36] 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R +ABT-333+RIBAVIRIN ACHIEVED SVR12 IN MORE THAN 90% OF TREATMENT-NAIVE HCV GENOTYPE-1-INFECTED SUBJECTS AND 47% OF PREVIOUS NON-RESPONDERS
    Poordad, F.
    Lawitz, E.
    Kowdley, K. V.
    Everson, G. T.
    Freilich, B.
    Cohen, D.
    Siggelkow, S.
    Heckaman, M.
    Menon, R.
    Pilot-Matias, T.
    Podsadecki, T.
    Bernstein, B.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S549 - S550
  • [37] Low Relapse Rate Leads to High Concordance of Sustained Virologic Response (SVR) at 12 Weeks With SVR at 24 Weeks After Treatment With ABT-450/Ritonavir, Ombitasvir, and Dasabuvir Plus Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection in the AVIATOR Study
    Poordad, Fred
    Agarwal, Kosh
    Younes, Ziad
    Cohen, Daniel
    Xie, Wangang
    Podsadecki, Thomas
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (04) : 608 - 610
  • [38] ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients Receiving Stable Opioid Substitution Treatment: Pooled Analysis of Efficacy and Safety in Phase 2 and Phase 3 Trials
    Puoti, Massimo
    Cooper, Curtis
    Sulkowski, Mark S.
    Foster, Graham R.
    Berg, Thomas
    Villa, Erica
    Rodriguez-Perez, Federico
    Rustgi, Vinod
    Wyles, David L.
    King, Martin
    McGovern, Barbara H.
    Wedemeyer, Heiner
    HEPATOLOGY, 2014, 60 : 1135A - 1136A
1234